Eliksa Therapeutics

Private

Doylestown, PennsylvaniaHealthcare & Life Scienceshttps://www.eliksa.com/

Last Round

Strategic

Oct 29, 2025

Company Overview

Eliksa Therapeutics is a biotechnology company that develops novel medicines for a range of debilitating diseases using the regenerative properties of amniotic fluid and amniotic membrane.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicineepidermolysis bullosaEBamniotic fluid secretomebiotechnologyrare diseaseorphan drugtissue repairbiological eye dropophthalmologycell-free therapyclinical trialbiologicsinflammation managementdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eliksa Therapeutics Comparables

Compare Eliksa Therapeutics with similar companies based on industry and business-model similarity.

Eliksa Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Nova Anchora	73%
Castle Creek Biosciences	71%
RHEACELL GmbH & Co. KG	71%

View all Comparables

Eliksa Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Oct 29, 2025
Seed	Jul 19, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Armen Karamanian

Co-Founder & CEO

Founding Team

Eliksa Therapeutics Investors

Notable investors and investment history

Eliksa Therapeutics investors
Investor	Rounds
Benjamin Franklin Technology Partners	Seed
Militia Hill Ventures	Seed
BioAdvance Capital	Seed
DEBRA Research gGmbH	Strategic

View all Investors

Eliksa Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Eliksa Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Eliksa Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDoylestown, Pennsylvania

Employee Range7

Year Founded2021

Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.